MedPath

Endoscopic Evaluation After Esophagectomy

Completed
Conditions
Esophageal Neoplasms
Anastomotic Leak
Ischemia
Constriction
Interventions
Procedure: Patients after esophagectomy
Registration Number
NCT02703142
Lead Sponsor
Nagasaki University
Brief Summary

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Detailed Description

Gastric conduit ischemia or anastomotic breakdown after esophagectomy with cervical esophagogastrostomy often cause severe complications, such as leakage, necrotic organs, and strictures. However the evaluation and prevention before developing gastric conduit ischemia have been established. The investigators have built a hypothesis that the evaluation for gastric mucosal ischemia in early phase after esophagectomy predict the complication of gastric conduit. Thus, the purpose of this study is the safety and efficacy of endoscopic evaluation about reconstructive organs after esophagectomy. The investigators evaluate endoscopic predictions using classifications in acute phase after esophagogastrostomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Malignant or end-stage benign esophageal disease.
  • Esophagectomy with reconstruction by a gastric pull-up.
Exclusion Criteria
  • Severe heart failure and pulmonary dysfunction
  • Severe renal and liver dysfunction
  • Allergenic history
  • Pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients after esophagectomyPatients after esophagectomyEndoscopic examinations are performed at 1, 8, and 15 postoperative days. Endoscopic examination is added when abnormal findings are demonstrated.
Primary Outcome Measures
NameTimeMethod
Number of participants with endoscopy-related adverse events as assessed by Clavien-Dindo ClassificationFrom 1 to 29 days after esophagectomy
Number of participants with the classification of gastric conduit ischemia by endoscopic findingsFrom 1 to 15 days after esophagectomy
Number of participants with the major complications of gastric conduit (strictures, leakage, necrosis)From 1 to 29 days after esophagectomy
Secondary Outcome Measures
NameTimeMethod
Biological examination of the mucosal biopsy of gastric conduit as assessed by the scoring system for immunohistochemical stainingFrom 1 to 29 days after esophagectomy

The scoring system refer to the article entitled a scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group (J Clin Pathol. 1997 Oct; 50(10): 801-804.)

Biological examination of the mucosal biopsy of gastric conduit as assessed by the ischemia related RNA copy numberFrom 1 to 29 days after esophagectomy
Biological examination of gastric conduit as assessed by the Mitochondrial DNA copy numberFrom 1 to 29 days after esophagectomy

Trial Locations

Locations (1)

Nagasaki University Hospital

🇯🇵

Nagasaki, Japan

© Copyright 2025. All Rights Reserved by MedPath